355 related articles for article (PubMed ID: 17929268)
1. Modulation of beta-catenin-mediated TCF-signalling in prostate cancer cell lines by wild-type and mutant p53.
Prowald A; Cronauer MV; von Klot C; Eilers T; Rinnab L; Herrmann T; Spindler KD; Montenarh M; Jonas U; Burchardt M
Prostate; 2007 Dec; 67(16):1751-60. PubMed ID: 17929268
[TBL] [Abstract][Full Text] [Related]
2. Axin downregulates TCF-4 transcription via beta-catenin, but not p53, and inhibits the proliferation and invasion of lung cancer cells.
Yang LH; Xu HT; Han Y; Li QC; Liu Y; Zhao Y; Yang ZQ; Dong QZ; Miao Y; Dai SD; Wang EH
Mol Cancer; 2010 Feb; 9():25. PubMed ID: 20122174
[TBL] [Abstract][Full Text] [Related]
3. Regulation of human nitric oxide synthase 2 expression by Wnt beta-catenin signaling.
Du Q; Park KS; Guo Z; He P; Nagashima M; Shao L; Sahai R; Geller DA; Hussain SP
Cancer Res; 2006 Jul; 66(14):7024-31. PubMed ID: 16849547
[TBL] [Abstract][Full Text] [Related]
4. Identification of Tcf-4 as a transcriptional target of p53 signalling.
Rother K; Johne C; Spiesbach K; Haugwitz U; Tschöp K; Wasner M; Klein-Hitpass L; Möröy T; Mössner J; Engeland K
Oncogene; 2004 Apr; 23(19):3376-84. PubMed ID: 14990988
[TBL] [Abstract][Full Text] [Related]
5. Sox17 and Sox4 differentially regulate beta-catenin/T-cell factor activity and proliferation of colon carcinoma cells.
Sinner D; Kordich JJ; Spence JR; Opoka R; Rankin S; Lin SC; Jonatan D; Zorn AM; Wells JM
Mol Cell Biol; 2007 Nov; 27(22):7802-15. PubMed ID: 17875931
[TBL] [Abstract][Full Text] [Related]
6. [Mechanism of Wnt signaling pathway regulation by a truncated mutant of Axin2 in colorectal cancer].
Wang FW; Wen L; Zhu SW; Yao Q; Cai YM; Ma G
Ai Zheng; 2007 Oct; 26(10):1041-6. PubMed ID: 17927870
[TBL] [Abstract][Full Text] [Related]
7. Ionomycin downregulates beta-catenin/Tcf signaling in colon cancer cell line.
Park CH; Hahm ER; Lee JH; Jung KC; Rhee HS; Yang CH
Carcinogenesis; 2005 Nov; 26(11):1929-33. PubMed ID: 15930030
[TBL] [Abstract][Full Text] [Related]
8. Positive inter-regulation between beta-catenin/T cell factor-4 signaling and endothelin-1 signaling potentiates proliferation and survival of prostate cancer cells.
Sun P; Xiong H; Kim TH; Ren B; Zhang Z
Mol Pharmacol; 2006 Feb; 69(2):520-31. PubMed ID: 16291872
[TBL] [Abstract][Full Text] [Related]
9. Activation of the canonical WNT signaling pathway promotes ovarian surface epithelial proliferation without inducing β-catenin/Tcf-mediated reporter expression.
Usongo M; Li X; Farookhi R
Dev Dyn; 2013 Mar; 242(3):291-300. PubMed ID: 23239518
[TBL] [Abstract][Full Text] [Related]
10. Activation of p53-dependent apoptosis by acute ablation of glycogen synthase kinase-3beta in colorectal cancer cells.
Ghosh JC; Altieri DC
Clin Cancer Res; 2005 Jun; 11(12):4580-8. PubMed ID: 15958644
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of nordihydroguaiaretic acid on β-catenin/Tcf signalling in β-catenin-activated cells.
Park S; Lee J
Cell Biochem Funct; 2011; 29(1):22-9. PubMed ID: 21264886
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of beta-catenin by activated p53.
Sadot E; Geiger B; Oren M; Ben-Ze'ev A
Mol Cell Biol; 2001 Oct; 21(20):6768-81. PubMed ID: 11564862
[TBL] [Abstract][Full Text] [Related]
13. Crosstalk between NF-kappaB/p65 and beta-catenin/TCF4/p300 signalling pathways through alterations in GSK-3beta expression during trans-differentiation of endometrial carcinoma cells.
Saegusa M; Hashimura M; Kuwata T; Hamano M; Okayasu I
J Pathol; 2007 Sep; 213(1):35-45. PubMed ID: 17607667
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of beta-catenin/Tcf signaling by flavonoids.
Park S; Choi J
J Cell Biochem; 2010 Aug; 110(6):1376-85. PubMed ID: 20564233
[TBL] [Abstract][Full Text] [Related]
15. Coiled-coil domain containing 85B suppresses the beta-catenin activity in a p53-dependent manner.
Iwai A; Hijikata M; Hishiki T; Isono O; Chiba T; Shimotohno K
Oncogene; 2008 Mar; 27(11):1520-6. PubMed ID: 17873903
[TBL] [Abstract][Full Text] [Related]
16. Redundant expression of canonical Wnt ligands in human breast cancer cell lines.
Benhaj K; Akcali KC; Ozturk M
Oncol Rep; 2006 Mar; 15(3):701-7. PubMed ID: 16465433
[TBL] [Abstract][Full Text] [Related]
17. Activation of beta-catenin signaling in prostate cancer by peptidyl-prolyl isomerase Pin1-mediated abrogation of the androgen receptor-beta-catenin interaction.
Chen SY; Wulf G; Zhou XZ; Rubin MA; Lu KP; Balk SP
Mol Cell Biol; 2006 Feb; 26(3):929-39. PubMed ID: 16428447
[TBL] [Abstract][Full Text] [Related]
18. Induction of p16INK4A mediated by beta-catenin in a TCF4-independent manner: implications for alterations in p16INK4A and pRb expression during trans-differentiation of endometrial carcinoma cells.
Saegusa M; Hashimura M; Kuwata T; Hamano M; Okayasu I
Int J Cancer; 2006 Nov; 119(10):2294-303. PubMed ID: 16858682
[TBL] [Abstract][Full Text] [Related]
19. Mixed lineage kinase 3 modulates β-catenin signaling in cancer cells.
Thylur RP; Senthivinayagam S; Campbell EM; Rangasamy V; Thorenoor N; Sondarva G; Mehrotra S; Mishra P; Zook E; Le PT; Rana A; Rana B
J Biol Chem; 2011 Oct; 286(43):37470-82. PubMed ID: 21880738
[TBL] [Abstract][Full Text] [Related]
20. A Tcf/Lef element within the enhancer region of the human NANOG gene plays a role in promoter activation.
Kim CG; Chung IY; Lim Y; Lee YH; Shin SY
Biochem Biophys Res Commun; 2011 Jul; 410(3):637-42. PubMed ID: 21689639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]